Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1974 1
1975 1
1976 3
1977 4
1978 1
1979 5
1980 2
1981 6
1982 2
1983 9
1984 10
1985 7
1986 22
1987 21
1988 19
1989 16
1990 24
1991 18
1992 29
1993 35
1994 30
1995 26
1996 34
1997 48
1998 32
1999 55
2000 47
2001 55
2002 74
2003 58
2004 77
2005 77
2006 101
2007 103
2008 115
2009 142
2010 146
2011 146
2012 220
2013 252
2014 233
2015 224
2016 249
2017 290
2018 287
2019 335
2020 389
2021 497
2022 505
2023 451
2024 480
2025 178

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,491 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Roach, 20NK, 5BAuthor
Page 1
Improvements in Patient-Reported Outcomes in Relapsed or Refractory Large B-Cell Lymphoma Patients Treated With Epcoritamab.
Phillips T, Lugtenburg P, Kalsekar A, Mutebi A, Wang A, Blaedel J, Kosa K, Martin S, Sacchi M, Kilavuz N, Thieblemont C. Phillips T, et al. Clin Lymphoma Myeloma Leuk. 2024 Mar;24(3):e78-e87.e2. doi: 10.1016/j.clml.2023.11.005. Epub 2023 Nov 27. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38151388 Free article.
FACT-Lym and EQ-5D-3L score changes from baseline (CFB) to cycle 9 or end of treatment were interpreted using published minimally important differences (MID). ...FACT-Lym scores exceeded MID thresholds: mean (SD) CFB were 4.4 (15.2), MID 3.0 to 7.0 (FACT-General); 5.9 (7.6 …
FACT-Lym and EQ-5D-3L score changes from baseline (CFB) to cycle 9 or end of treatment were interpreted using published minimally imp …
The EQ-5D and the EuroQol Group.
Lloyd A, Pickard AS. Lloyd A, et al. Value Health. 2019 Jan;22(1):21-22. doi: 10.1016/j.jval.2018.12.002. Value Health. 2019. PMID: 30661629 Free article. No abstract available.
EQ-5D-5L Population Norms for China Derived From a National Health Survey.
Li DL, Wang ZT, Nie XY, Luo N, Wu YB, Pan CW, Wang P. Li DL, et al. Value Health. 2024 Aug;27(8):1108-1120. doi: 10.1016/j.jval.2024.04.014. Epub 2024 Apr 26. Value Health. 2024. PMID: 38677363
OBJECTIVES: To develop the EQ-5D-5L (5L) population norms for China and to assess the relationship between various factors and 5L data. ...Participants reported considerably more problems in anxiety/depression (26.2%) and pain/discomfort (22.2%) dimensions. The gend …
OBJECTIVES: To develop the EQ-5D-5L (5L) population norms for China and to assess the relationship between various factors and 5L dat …
Atlas Argentino de Calidad de Vida Relacionada con la Salud: Análisis de los datos de la Encuesta Nacional de Factores de Riesgo por Provincias.
Augustovski F, Rey-Ares L, Gibbons L. Augustovski F, et al. Value Health Reg Issues. 2013 Dec;2(3):398-404. doi: 10.1016/j.vhri.2013.10.006. Epub 2013 Dec 12. Value Health Reg Issues. 2013. PMID: 29702777 Free article. Spanish.
METHODS: Secondary cross-sectional study analyzing EQ-5D-3L responses. The variables of interest were self-reported visual analog scale in a 0-1 scale (SR-VAS), as well as time-trade off (TTO) and VAS preference values (PV). ...RESULTS: The survey included 41.392 subjects; …
METHODS: Secondary cross-sectional study analyzing EQ-5D-3L responses. The variables of interest were self-reported visual analog sca …
Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review.
Poudel N, Fahim SM, Qian J, Garza K, Chaiyakunapruk N, Ngorsuraches S. Poudel N, et al. J Med Econ. 2022 Jan-Dec;25(1):571-582. doi: 10.1080/13696998.2022.2066441. J Med Econ. 2022. PMID: 35416095 Free article.
OBJECTIVES: (1) To descriptively compare the selected elements of valuation methods for EQ-5D-5L value set studies, (2) to compare the characteristics of the value sets, and (3) to examine the associations between the selected elements of valuation methods and the EQ-5D …
OBJECTIVES: (1) To descriptively compare the selected elements of valuation methods for EQ-5D-5L value set studies, (2) to compare th …
Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis.
Yang Z, Li S, Wang X, Chen G. Yang Z, et al. J Dermatolog Treat. 2022 Mar;33(2):1029-1036. doi: 10.1080/09546634.2020.1800571. Epub 2020 Aug 9. J Dermatolog Treat. 2022. PMID: 32716651 Free article.
For meta-analysis, we identified 70 utility scores from 59 studies: 22 for plaque psoriasis, 26 for psoriasis as a general condition, and 22 for psoriatic arthritis. ...Heterogeneity exists among different EQ-5D utility values found in the literature....
For meta-analysis, we identified 70 utility scores from 59 studies: 22 for plaque psoriasis, 26 for psoriasis as a general condition, …
Patient satisfaction with cluneal nerve entrapment surgery.
Kim K, Kokubo R, Isu T, Morimoto D, Morita A. Kim K, et al. Acta Neurochir (Wien). 2022 Oct;164(10):2667-2671. doi: 10.1007/s00701-022-05344-1. Epub 2022 Aug 16. Acta Neurochir (Wien). 2022. PMID: 35972558
We recorded patient satisfaction with this treatment. METHODS: We included 22 consecutive patients who had undergone surgery for unilateral cluneal nerve entrapment (superior: n = 17, middle: n = 5). ...RESULTS: LBP was ameliorated in all 22 patients; their NRS, ODI …
We recorded patient satisfaction with this treatment. METHODS: We included 22 consecutive patients who had undergone surgery for unil …
EQ-5D: a plea for accurate nomenclature.
Brooks R, Boye KS, Slaap B. Brooks R, et al. J Patient Rep Outcomes. 2020 Jul 3;4(1):52. doi: 10.1186/s41687-020-00222-9. J Patient Rep Outcomes. 2020. PMID: 32620995 Free PMC article.
In order to standardise nomenclature, the EuroQol Group agreed in 2001 on a terminology glossary containing 12 items; this was recently revised and augmented to include 22 items and can be found on the Group's website ( www.euroqol.org ). Since 2009, EQ-5D has been …
In order to standardise nomenclature, the EuroQol Group agreed in 2001 on a terminology glossary containing 12 items; this was recently revi …
Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L).
Crump RT, Lai E, Liu G, Janjua A, Sutherland JM. Crump RT, et al. Int Forum Allergy Rhinol. 2017 May;7(5):480-487. doi: 10.1002/alr.21917. Epub 2017 Feb 9. Int Forum Allergy Rhinol. 2017. PMID: 28182331
Study participants completed both the SNOT-22 and the EQ-5D-3L. Ordinary least squares was used for 3 models that estimated the EQ-5D-3L utility values as a function of the SNOT-22 items. RESULTS: A total of 232 participants completed both the SNOT- …
Study participants completed both the SNOT-22 and the EQ-5D-3L. Ordinary least squares was used for 3 models that estimated th …
Temporal properties of positive and negative defocus on emmetropization.
Zhu X, Kang P, Troilo D, Benavente-Perez A. Zhu X, et al. Sci Rep. 2022 Mar 4;12(1):3582. doi: 10.1038/s41598-022-07621-6. Sci Rep. 2022. PMID: 35246571 Free PMC article.
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5D; OS: plano). Two control groups wore + 5D (n = 5) or - 5D (n = 13) lenses continuously for 9 h/day. ...Interrupting defo …
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5 …
5,491 results